Aster DM Healthcare Reaffirms Merger Commitment Amid Strong Shareholder Support

Aster DM Healthcare Limited (BSE: 540975, NSE: ASTERDM) updated stakeholders on its proposed Scheme of Amalgamation with Quality Care India Limited, emphasizing robust shareholder backing and governance enhancements.

The merger, potentially creating one of India's top 3 hospital chains and the largest transaction in the hospital space, received 99.998% approval from shareholders for the preceding Share Swap. It promises a diversified presence across 9 states and 25 cities, leadership in key markets, a holistic platform with 6,690+ clinicians serving 2.0 million patients quarterly, stronger financial metrics, expansion opportunities, and 10-15% EBITDA upside from synergies (based on FY24 pro-forma).

The equity shareholders' meeting is scheduled for Tuesday, March 10, 2026, at 10:00 AM IST via Video Conferencing/Other Audio Visual Means, with remote e-voting from March 6, 9:00 AM to March 9, 5:00 PM IST. Notices were issued on February 4, 2026.

Addressing stakeholder queries, the company highlighted promoter rights for Aster Promoters and Blackstone-customary for such deals-to ensure alignment, including diminishing director nomination rights waived below 10% shareholding post-scheme. Board committees will maintain independent director representation per law, with unresolved matters escalating to the Board. Promoters commit to waiving committee nomination rights post-scheme, with Articles of Association revisions to follow.

Shares of Aster DM Healthcare Limited was last trading in BSE at Rs. 647.00 as compared to the previous close of Rs. 652.30. The total number of shares traded during the day was 52250 in over 4474 trades.

The stock hit an intraday high of Rs. 652.05 and intraday low of 555.70. The net turnover during the day was Rs. 33376813.00.

Source : Equity Bulls

Keywords

AsterDMHealthcare INE914M01019 HealthcareServices Merger QualityCareIndia